NSAID vs. Narcotics
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02915055|
Recruitment Status : Completed
First Posted : September 26, 2016
Last Update Posted : May 8, 2017
This will be a single-center, prospective observational study. The study will compare post-operative pain scores and narcotic consumption between two groups of patients - one cohort will receive ibuprofen (Motrin) and Percocet (to be used as needed) while the other cohort will receive only Percocet. Both pain management options are considered to be standard of care.
The primary objective of the study is to compare patients' reported pain and narcotic use following meniscectomy, and determine if NSAIDs can provide adequate pain relief.
|Condition or disease||Intervention/treatment|
|Multimodal Analgesia Nonsteroidal Anti-inflammatory Drugs||Drug: Ibuprofen 600 mg Drug: standard oxycodone/acetaminophen|
|Study Type :||Observational|
|Actual Enrollment :||77 participants|
|Official Title:||Multimodal Analgesia With NSAID vs. Narcotics Alone for Post-operative Meniscectomy: A Prospective Observational Study|
|Actual Study Start Date :||September 1, 2016|
|Actual Primary Completion Date :||March 1, 2017|
|Actual Study Completion Date :||March 1, 2017|
|Patients with pain following knee arthroscopic meniscectomy||
Drug: Ibuprofen 600 mg
Ibuprofen 600 mg to be taken every 8 hours (TID) as needed (PRN
Drug: standard oxycodone/acetaminophen
Other Name: Percocet
- Visual analogue scale (VAS) score [ Time Frame: 4 Hours ]Scale consisting of a drawn line from 0 to 100 - you will be asked to mark where you believe your pain is (100 being worse pain).
- Pain Verbal Rating Scale [ Time Frame: 4 Hours ]Verbal rating scale, consisting of 4 points (0 = no pain, 1 = mild, 2 = moderate, and 3 = severe).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02915055
|United States, New York|
|New York University School of Medicine|
|New York, New York, United States, 10016|
|Principal Investigator:||Kirk Campbell, MD||New York University Medical School|